PMID: 6990673Feb 1, 1980Paper

Beta-cell function and metabolic control in insulin treated diabetics

Acta Endocrinologica
S MadsbadI Transbøl

Abstract

In a random one day study beta-cell function was evaluated in 210 insulin treated diabetics by the serum C-peptide concentration 6 min after iv injection of 1 mg of glucagon. Sixty-five patients (31%) had residual beta-cell function. As a group these patients were characterized by having a higher age at onset of diabetes (P less than 0.01), a shorter duration of disease (P less than 0.01) and by receiving a smaller dose of insulin (P less than 0.01). However, their quality of metabolic control did not differ from the patients without beta-cell function. Although the concentrations of post-stimulatory C-peptide correlated inversely with both the 24-hour glycosuria (P less than 0.01) and the fasting blood glucose concentrations (P less than 0.02), only a subgroup with C-peptide concentrations exceeding 0.30 pmol/ml showed a definitely better degree of metabolic control than those without beta-cell function. As this subgroup also received the smallest dose of insulin these observations suggest that maintenance of beta-cell function above this level facilitates good metabolic control. Evidence is presented suggesting that measurements of the 24-hour glycosuria undertaken in a diabetes clinic create a too optimistic impression of th...Continue Reading

Citations

Sep 1, 1994·Diabetologia·J WahrenH Wallberg-Henriksson
Nov 1, 1979·Diabetologia·P McNairI Transbøl
Jan 13, 2006·Diabetologia·E B TsaiK C Herold
Apr 8, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·P McNairI Transbøl
Oct 1, 1995·Diabetes Research and Clinical Practice·M N ElbagirC Berne
Aug 1, 1990·Journal of Internal Medicine·S Madsbad
Nov 1, 1987·Archives of Disease in Childhood·M D HockingM Nattrass
Jan 1, 1984·Critical Reviews in Clinical Laboratory Sciences·A M Bonser, P Garcia-Webb
Nov 1, 1985·Scandinavian Journal of Clinical and Laboratory Investigation·P KoskinenP Seppälä
Feb 1, 1982·Australian and New Zealand Journal of Medicine·C GlatthaarE A Espiner
Jan 1, 1986·Diabetic Medicine : a Journal of the British Diabetic Association·S MadsbadC Binder
Jun 1, 1987·Acta Paediatrica Japonica; Overseas Edition·A TanaeI Hibi
Nov 1, 1982·Acta paediatrica Scandinavica·M KnipH K Akerblom
Jan 1, 1985·Acta Paediatrica Scandinavica. Supplement·L Blom, G Dahlquist
Feb 1, 1981·European Journal of Clinical Investigation·P McNairI Transbøl
Dec 1, 1984·Acta Anaesthesiologica Scandinavica·S MadsbadJ Hilsted
Jan 1, 1986·Diabetes/metabolism Reviews·O K Faber, C Binder
Nov 25, 2005·Diabetes·Nicole A SherryKevan C Herold
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·S Madsbad
May 1, 1982·Acta Medica Scandinavica·K KølendorfB Broch-Møller
Jun 16, 2021·Medicine and Science in Sports and Exercise·Olivia McCarthyRichard M Bracken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.